chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive for Covid-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Contact Information Updated
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Vaccination site erythema
Clinical narrative: woke up with a big red irritations s that looks like a silver dollar; other spot looks like the size of a dime where he got his shot; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (woke up with a big red irritations s that looks like a silver dollar) and VACCINATION SITE ERYTHEMA (other spot looks like the size of a dime where he got his shot) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced ERYTHEMA (woke up with a big red irritations s that looks like a silver dollar) and VACCINATION SITE ERYTHEMA (other spot looks like the size of a dime where he got his shot). At the time of the report, ERYTHEMA (woke up with a big red irritations s that looks like a silver dollar) and VACCINATION SITE ERYTHEMA (other spot looks like the size of a dime where he got his shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Her back was killing her; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Her back was killing her) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Her back was killing her). At the time of the report, BACK PAIN (Her back was killing her) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information included Aleve and Advil; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: myalgia, described as muscle aches and muscle pains; fever; This spontaneous case was reported by a health care professional and describes the occurrence of MYALGIA (myalgia, described as muscle aches and muscle pains) and PYREXIA (fever) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concomitant products included levothlyroxine for an unknown indication.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced MYALGIA (myalgia, described as muscle aches and muscle pains) and PYREXIA (fever). At the time of the report, MYALGIA (myalgia, described as muscle aches and muscle pains) and PYREXIA (fever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The symptoms have not been treated. The HCP wife of the patient asked can the patient take Tylenol for his symptoms.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, Vaccination site pruritus
Clinical narrative: ITCHINESS ON THE ARM; received Pfizer for second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (ITCHINESS ON THE ARM) and INTERCHANGE OF VACCINE PRODUCTS (received Pfizer for second vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received Pfizer for second vaccine). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (ITCHINESS ON THE ARM). On 20-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (received Pfizer for second vaccine) had resolved. At the time of the report, VACCINATION SITE PRURITUS (ITCHINESS ON THE ARM) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication not received. Concomitant medication not received   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-MAY-2021 and contains significant information. Added one additional event Vaccination site pruritus
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Decreased appetite, Diarrhoea, Fatigue, Feeling cold
Clinical narrative: loss of appetite; loss of taste; diarrhea; vomiting; extreme fatigue; Felt cold; sore arm; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Felt cold), PAIN IN EXTREMITY (sore arm), DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste) and DIARRHOEA (diarrhea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING COLD (Felt cold), PAIN IN EXTREMITY (sore arm) and FATIGUE (Very tired). On 12-Apr-2021, the patient experienced FATIGUE (extreme fatigue). On 17-Apr-2021, the patient experienced DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste), DIARRHOEA (diarrhea) and VOMITING (vomiting). The patient was treated with ACETYLSALICYLIC ACID (ALKA-SELTZER) at an unspecified dose and frequency. On 16-Apr-2021, FATIGUE (extreme fatigue) had resolved. At the time of the report, FEELING COLD (Felt cold), PAIN IN EXTREMITY (sore arm), DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste), DIARRHOEA (diarrhea), FATIGUE (Very tired) and VOMITING (vomiting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: loss of appetite; loss of taste; diarrhea; vomiting; extreme fatigue; Felt cold; sore arm; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Felt cold), PAIN IN EXTREMITY (sore arm), DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste) and DIARRHOEA (diarrhea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING COLD (Felt cold), PAIN IN EXTREMITY (sore arm) and FATIGUE (Very tired). On 12-Apr-2021, the patient experienced FATIGUE (extreme fatigue). On 17-Apr-2021, the patient experienced DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste), DIARRHOEA (diarrhea) and VOMITING (vomiting). The patient was treated with ACETYLSALICYLIC ACID (ALKA-SELTZER) at an unspecified dose and frequency. On 16-Apr-2021, FATIGUE (extreme fatigue) had resolved. At the time of the report, FEELING COLD (Felt cold), PAIN IN EXTREMITY (sore arm), DECREASED APPETITE (loss of appetite), AGEUSIA (loss of taste), DIARRHOEA (diarrhea), FATIGUE (Very tired) and VOMITING (vomiting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported. Treatment include Heating pad.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Pain
Clinical narrative: shingles; pain; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) and PAIN (pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced HERPES ZOSTER (shingles) and PAIN (pain). At the time of the report, HERPES ZOSTER (shingles) and PAIN (pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-085610, US-MODERNATX, INC.-MOD-2021-085610 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-085610:case for wife US-MODERNATX, INC.-MOD-2021-085610:case for husband
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dry mouth, Fatigue, Feeling abnormal, Hypersensitivity
Clinical narrative: Dizzy; Little more tired; He had cotton mouth; He was parched; He thought he was dying/Felt like he was buzzed or had taken drugs; Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (He thought he was dying/Felt like he was buzzed or had taken drugs), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizzy), DRY MOUTH (He had cotton mouth) and THIRST (He was parched) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037b21a and MOD044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 rapid diagnostic test (Positive) on 27-Oct-2020.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced FEELING ABNORMAL (He thought he was dying/Felt like he was buzzed or had taken drugs), HYPERSENSITIVITY (Allergic reaction), DRY MOUTH (He had cotton mouth) and THIRST (He was parched). On 22-Apr-2021, the patient experienced FATIGUE (Little more tired). On an unknown date, the patient experienced DIZZINESS (Dizzy). At the time of the report, FEELING ABNORMAL (He thought he was dying/Felt like he was buzzed or had taken drugs), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizzy), DRY MOUTH (He had cotton mouth) and THIRST (He was parched) had resolved and FATIGUE (Little more tired) outcome was unknown.            Concomitant medications were not provided by the reporter.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Treatment for the event included IV (intravenous) therapy in emergency room.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-085424 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Patient demographics was added.Patient'smedical history was added1st dose date and time of administration was added.Event statrt date and outcome of the event was updated.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Thirst
Clinical narrative: Dizzy; Little more tired; He had cotton mouth; He was parched; He thought he was dying/Felt like he was buzzed or had taken drugs; Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (He thought he was dying/Felt like he was buzzed or had taken drugs), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizzy), DRY MOUTH (He had cotton mouth) and THIRST (He was parched) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037b21a and MOD044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 rapid diagnostic test (Positive) on 27-Oct-2020.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced FEELING ABNORMAL (He thought he was dying/Felt like he was buzzed or had taken drugs), HYPERSENSITIVITY (Allergic reaction), DRY MOUTH (He had cotton mouth) and THIRST (He was parched). On 22-Apr-2021, the patient experienced FATIGUE (Little more tired). On an unknown date, the patient experienced DIZZINESS (Dizzy). At the time of the report, FEELING ABNORMAL (He thought he was dying/Felt like he was buzzed or had taken drugs), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizzy), DRY MOUTH (He had cotton mouth) and THIRST (He was parched) had resolved and FATIGUE (Little more tired) outcome was unknown.            Concomitant medications were not provided by the reporter.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Treatment for the event included IV (intravenous) therapy in emergency room.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-085424 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Patient demographics was added.Patient'smedical history was added1st dose date and time of administration was added.Event statrt date and outcome of the event was updated.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Aderall, Anti-Thyroid medication, Progestrone, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and DULOXETINE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching on the hands and face 15 minutes after the shot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on the hands and face 15 minutes after the shot) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to animals. Concomitant products included OXCARBAZEPINE (TRILEPTAL), CLONAZEPAM (KLONOPIN), OLANZAPINE (ZYPREXA) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced PRURITUS (Itching on the hands and face 15 minutes after the shot). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching on the hands and face 15 minutes after the shot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: A week later, my left hip and my left shoulder, it felt like my hip was going to break. It was more intense than with the first shot.; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (A week later, my left hip and my left shoulder, it felt like my hip was going to break. It was more intense than with the first shot.) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced ARTHRALGIA (A week later, my left hip and my left shoulder, it felt like my hip was going to break. It was more intense than with the first shot.). On 17-Apr-2021, ARTHRALGIA (A week later, my left hip and my left shoulder, it felt like my hip was going to break. It was more intense than with the first shot.) had resolved. Not Provided          No concomitant medications reported. No treatment information provided.  The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-085396 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Oropharyngeal pain, Productive cough, Sinusitis
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat and it's getting worse), DYSPHONIA (Voice started to sound weird), SINUSITIS (Sinuses are draining a little bit) and PRODUCTIVE COUGH (Hawking up loogies) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter.  Concomitant products included ACYCLOVIR [ACICLOVIR], VENLAFAXINE HYDROCHLORIDE (EFFEXOR), LITHIUM, MIRTAZAPINE, CLONAZEPAM and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication. On 20-Apr-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021 at 1:00 PM, the patient experienced OROPHARYNGEAL PAIN (Sore throat and it's getting worse). On 21-Apr-2021, the patient experienced DYSPHONIA (Voice started to sound weird) and PRODUCTIVE COUGH (Hawking up loogies). On an unknown date, the patient experienced SINUSITIS (Sinuses are draining a little bit). At the time of the report, OROPHARYNGEAL PAIN (Sore throat and it's getting worse) had not resolved and DYSPHONIA (Voice started to sound weird), SINUSITIS (Sinuses are draining a little bit) and PRODUCTIVE COUGH (Hawking up loogies) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product also included depot shots every three months. Treatment information was not provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever early morning around 99.4F, 99.5F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever early morning around 99.4F, 99.5F) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from 15-Mar-2021 to 31-Mar-2021. Concomitant products included ASA for Clot blood.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced PYREXIA (Fever early morning around 99.4F, 99.5F). At the time of the report, PYREXIA (Fever early morning around 99.4F, 99.5F) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant medications also include some other medications. No treatment medications reported.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation
Clinical narrative: an atrial fibrillation episode; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ATRIAL FIBRILLATION (an atrial fibrillation episode) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation. Concomitant products included DILTIAZEM, ETRETINATE (TEGISON), APIXABAN (ELIQUIS), CALCITONIN, ATORVASTATIN CALCIUM (LIPITOR), ASPIRIN [ACETYLSALICYLIC ACID] and CHOLESTYRAMINE for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced ATRIAL FIBRILLATION (an atrial fibrillation episode). At the time of the report, ATRIAL FIBRILLATION (an atrial fibrillation episode) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. No treatment information was provided.  Company Comment: Based on current available information and the temporal association between product use and the start date of the event a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up received on 23-jun-2021 - Contact detail updated; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the event a causal relationship cannot be excluded.
Age: 76.0
Sex: U
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: received first dose of Moderna Covid-19 and received second dose of Pfizer Covid-19 vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (received first dose of Moderna Covid-19 and received second dose of Pfizer Covid-19 vaccine.) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and EW0171) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced WRONG PRODUCT ADMINISTERED (received first dose of Moderna Covid-19 and received second dose of Pfizer Covid-19 vaccine.). At the time of the report, WRONG PRODUCT ADMINISTERED (received first dose of Moderna Covid-19 and received second dose of Pfizer Covid-19 vaccine.) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant medications were given No treatment information was provided
Sex: M
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: swollen lymph nodes; pain in the area of swollen lymph nodes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes) and LYMPH NODE PAIN (pain in the area of swollen lymph nodes) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes) and LYMPH NODE PAIN (pain in the area of swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes) and LYMPH NODE PAIN (pain in the area of swollen lymph nodes) outcome was unknown. Not Provided          No concomitant medications reported.   No treatment medications provided by the reporter.  Action taken with mRNA-1273 in response to events was not applicable.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Head discomfort, Headache, Inappropriate schedule of product administration, Injection site hypoaesthesia
Clinical narrative: Slight numbness injection site on left arm; Head is congested; Jaw area muscle tightness; Feels a little off; Slight ache in head; 2nd Shot after 42 Days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Shot after 42 Days), INJECTION SITE HYPOAESTHESIA (Slight numbness injection site on left arm), HEAD DISCOMFORT (Head is congested), MUSCLE TIGHTNESS (Jaw area muscle tightness) and FEELING ABNORMAL (Feels a little off) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Shot after 42 Days). On 21-Apr-2021, the patient experienced INJECTION SITE HYPOAESTHESIA (Slight numbness injection site on left arm), HEAD DISCOMFORT (Head is congested), MUSCLE TIGHTNESS (Jaw area muscle tightness), FEELING ABNORMAL (Feels a little off) and HEADACHE (Slight ache in head). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Shot after 42 Days), INJECTION SITE HYPOAESTHESIA (Slight numbness injection site on left arm), HEAD DISCOMFORT (Head is congested), MUSCLE TIGHTNESS (Jaw area muscle tightness), FEELING ABNORMAL (Feels a little off) and HEADACHE (Slight ache in head) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment medication was not provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness
Clinical narrative: Slight numbness injection site on left arm; Head is congested; Jaw area muscle tightness; Feels a little off; Slight ache in head; 2nd Shot after 42 Days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Shot after 42 Days), INJECTION SITE HYPOAESTHESIA (Slight numbness injection site on left arm), HEAD DISCOMFORT (Head is congested), MUSCLE TIGHTNESS (Jaw area muscle tightness) and FEELING ABNORMAL (Feels a little off) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Shot after 42 Days). On 21-Apr-2021, the patient experienced INJECTION SITE HYPOAESTHESIA (Slight numbness injection site on left arm), HEAD DISCOMFORT (Head is congested), MUSCLE TIGHTNESS (Jaw area muscle tightness), FEELING ABNORMAL (Feels a little off) and HEADACHE (Slight ache in head). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd Shot after 42 Days), INJECTION SITE HYPOAESTHESIA (Slight numbness injection site on left arm), HEAD DISCOMFORT (Head is congested), MUSCLE TIGHTNESS (Jaw area muscle tightness), FEELING ABNORMAL (Feels a little off) and HEADACHE (Slight ache in head) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment medication was not provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleeding for 12 min) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included Toprol for hypertension for an unknown indication. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced EPISTAXIS (nose bleeding for 12 min). At the time of the report, EPISTAXIS (nose bleeding for 12 min) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site is hot; Injection site is itchy; Swelling on injection arm; Injection site is red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site is hot), VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE SWELLING (Swelling on injection arm) and VACCINATION SITE ERYTHEMA (Injection site is red) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 10218467) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Injection site is hot), VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE SWELLING (Swelling on injection arm) and VACCINATION SITE ERYTHEMA (Injection site is red). At the time of the report, VACCINATION SITE WARMTH (Injection site is hot), VACCINATION SITE PRURITUS (Injection site is itchy), VACCINATION SITE SWELLING (Swelling on injection arm) and VACCINATION SITE ERYTHEMA (Injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L70A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information were Ibuprofen, Aspirin.   This case was linked to MOD-2021-085539 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Swelling of eyelid
Clinical narrative: Eyelids were very swollen; chills; bodyaches; fever; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (Eyelids were very swollen), CHILLS (chills), MYALGIA (bodyaches) and PYREXIA (fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) and IBUPROFEN (ADVIL 12 HOUR) for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced SWELLING OF EYELID (Eyelids were very swollen), CHILLS (chills), MYALGIA (bodyaches) and PYREXIA (fever). On 20-Apr-2021, CHILLS (chills), MYALGIA (bodyaches) and PYREXIA (fever) had resolved. On 22-Apr-2021, SWELLING OF EYELID (Eyelids were very swollen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  Concomitant medication included blood pressure medication.  Treatment medication included Benadryl and Advil for every four hours.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Feeling cold, Myalgia
Clinical narrative: hardly stay awake; exhausted; body tired/bodyaches; feels freezing; no energy; cold to touch; entire body sore; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (hardly stay awake), FATIGUE (exhausted), MYALGIA (body tired/bodyaches), CHILLS (feels freezing) and ASTHENIA (no energy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced SOMNOLENCE (hardly stay awake), FATIGUE (exhausted), MYALGIA (body tired/bodyaches), CHILLS (feels freezing), ASTHENIA (no energy), FEELING COLD (cold to touch) and PAIN (entire body sore). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (hardly stay awake), FATIGUE (exhausted), MYALGIA (body tired/bodyaches), CHILLS (feels freezing), ASTHENIA (no energy), FEELING COLD (cold to touch) and PAIN (entire body sore) outcome was unknown.            Treatment information not provided. List of concomitant medication were not given. Action taken with mRNA-1273 in response to the events was  not applicable
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Somnolence
Clinical narrative: hardly stay awake; exhausted; body tired/bodyaches; feels freezing; no energy; cold to touch; entire body sore; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (hardly stay awake), FATIGUE (exhausted), MYALGIA (body tired/bodyaches), CHILLS (feels freezing) and ASTHENIA (no energy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced SOMNOLENCE (hardly stay awake), FATIGUE (exhausted), MYALGIA (body tired/bodyaches), CHILLS (feels freezing), ASTHENIA (no energy), FEELING COLD (cold to touch) and PAIN (entire body sore). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (hardly stay awake), FATIGUE (exhausted), MYALGIA (body tired/bodyaches), CHILLS (feels freezing), ASTHENIA (no energy), FEELING COLD (cold to touch) and PAIN (entire body sore) outcome was unknown.            Treatment information not provided. List of concomitant medication were not given. Action taken with mRNA-1273 in response to the events was  not applicable
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19
Clinical narrative: covid-19; Lost taste & smell; Lost taste & smell; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (covid-19), AGEUSIA (Lost taste & smell) and ANOSMIA (Lost taste & smell) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced COVID-19 (covid-19), AGEUSIA (Lost taste & smell) and ANOSMIA (Lost taste & smell). At the time of the report, COVID-19 (covid-19), AGEUSIA (Lost taste & smell) and ANOSMIA (Lost taste & smell) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypoaesthesia, Muscle spasms, Pain in extremity
Clinical narrative: Left leg feels crampy; Fingers feel a little bit numb; Pain in left arm; Left arm to feel tired / Fingers feel tired; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Left leg feels crampy), HYPOAESTHESIA (Fingers feel a little bit numb), PAIN IN EXTREMITY (Pain in left arm) and FATIGUE (Left arm to feel tired / Fingers feel tired) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81), ROSUVASTATIN, LOSARTAN, METOPROLOL, OMEPRAZOLE and TRAZODONE for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Left leg feels crampy), HYPOAESTHESIA (Fingers feel a little bit numb), PAIN IN EXTREMITY (Pain in left arm) and FATIGUE (Left arm to feel tired / Fingers feel tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Left leg feels crampy), HYPOAESTHESIA (Fingers feel a little bit numb), PAIN IN EXTREMITY (Pain in left arm) and FATIGUE (Left arm to feel tired / Fingers feel tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) Blood pressure went up.         Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea
Clinical narrative: bad stomachache; terrible diarrhea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (bad stomachache), DIARRHOEA (terrible diarrhea) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (bad stomachache), DIARRHOEA (terrible diarrhea) and CHILLS (Chills). On 22-Apr-2021, DIARRHOEA (terrible diarrhea) had resolved. At the time of the report, CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Swelling was hot to touch; Bruise at injection site; Itching near the injection site; Arm at the injection site was really swollen up(finger's length amount of swelling); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Swelling was hot to touch), VACCINATION SITE BRUISING (Bruise at injection site), VACCINATION SITE PRURITUS (Itching near the injection site) and VACCINATION SITE SWELLING (Arm at the injection site was really swollen up(finger's length amount of swelling)) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Swelling was hot to touch), VACCINATION SITE BRUISING (Bruise at injection site), VACCINATION SITE PRURITUS (Itching near the injection site) and VACCINATION SITE SWELLING (Arm at the injection site was really swollen up(finger's length amount of swelling)). At the time of the report, VACCINATION SITE WARMTH (Swelling was hot to touch) outcome was unknown, VACCINATION SITE BRUISING (Bruise at injection site) and VACCINATION SITE PRURITUS (Itching near the injection site) had not resolved and VACCINATION SITE SWELLING (Arm at the injection site was really swollen up(finger's length amount of swelling)) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient had itching like a mosquito bite.  No concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment of events was reported. No concomitant medications were reported.   Reporter did not allow further contact